Literature DB >> 15071107

Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.

Reisuke H Takahashi1, Claudia G Almeida, Patrick F Kearney, Fangmin Yu, Michael T Lin, Teresa A Milner, Gunnar K Gouras.   

Abstract

Multiple lines of evidence implicate beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD), but the mechanisms whereby Abeta is involved remain unclear. Addition of Abeta to the extracellular space can be neurotoxic. Intraneuronal Abeta42 accumulation is also associated with neurodegeneration. We reported previously that in Tg2576 amyloid precursor protein mutant transgenic mice, brain Abeta42 localized by immunoelectron microscopy to, and accumulated with aging in, the outer membranes of multivesicular bodies, especially in neuronal processes and synaptic compartments. We now demonstrate that primary neurons from Tg2576 mice recapitulate the in vivo localization and accumulation of Abeta42 with time in culture. Furthermore, we demonstrate that Abeta42 aggregates into oligomers within endosomal vesicles and along microtubules of neuronal processes, both in Tg2576 neurons with time in culture and in Tg2576 and human AD brain. These Abeta42 oligomer accumulations are associated with pathological alterations within processes and synaptic compartments in Tg2576 mouse and human AD brains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071107      PMCID: PMC6729733          DOI: 10.1523/JNEUROSCI.5167-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  160 in total

1.  Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration.

Authors:  Haim Belinson; Zehavit Kariv-Inbal; Rakez Kayed; Eliezer Masliah; Daniel M Michaelson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Membrane localization of beta-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization.

Authors:  Rui-Qin Liu; Qing-Hua Zhou; Shang-Rong Ji; Qiang Zhou; Du Feng; Yi Wu; Sen-Fang Sui
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

Review 3.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

4.  Critical role of intraneuronal Aβ in Alzheimer's disease: technical challenges in studying intracellular Aβ.

Authors:  Gunnar K Gouras; Katarina Willén; Davide Tampellini
Journal:  Life Sci       Date:  2012-06-19       Impact factor: 5.037

Review 5.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.

Authors:  Martin J Sadowski; Joanna Pankiewicz; Henrieta Scholtzova; Pankaj D Mehta; Frances Prelli; David Quartermain; Thomas Wisniewski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

7.  Neuritic deposits of amyloid-beta peptide in a subpopulation of central nervous system-derived neuronal cells.

Authors:  Zoia Muresan; Virgil Muresan
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility.

Authors:  Li Ling Lee; HyungHo Ha; Young-Tae Chang; Matthew P DeLisa
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

9.  The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid.

Authors:  Han-Kyu Lee; Pravir Kumar; Qinghao Fu; Kenneth M Rosen; Henry W Querfurth
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

10.  Blocking the interaction between apolipoprotein E and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration.

Authors:  Magdalena A Kuszczyk; Sandrine Sanchez; Joanna Pankiewicz; Jungsu Kim; Malgorzata Duszczyk; Maitea Guridi; Ayodeji A Asuni; Patrick M Sullivan; David M Holtzman; Martin J Sadowski
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.